the cmv antibody incidence and titre range were similar in patients with symptomatic ( 37.9 % ) and idiopathic ( 37.5 % ) epilepsy , suggesting that the dph treatment was responsible for the decreased antibody occurrence in patients .
C0014544
epilepsy
C0031507
dph